U.K. becomes the first country to release detailed data on sponsors that fail to register clinical trials; Why the world’s most expensive drug might not be all that overpriced

Taking stock of the drug industry, from the lab to the medicine chest

March 28, 2024 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Adobe STAT+ | U.K. becomes the first country to release detailed data on sponsors that fail to register clinical trials "This is hugely significant as a global first," said Emma Thompson, advocacy and partnerships lead at the Cochrane network of researchers. By Ed Silverman STAT+ | Why the world's most expensive drug might not be all that overpriced In a country with runaway drug spending, gene therapies live on an island of rationality: They cost a fortune but the benefit is priceless. By Jason Mast STAT+ | Payments by drug and device makers to doctors remain widespread, but also vary considerably "But not all physicians participate in this," said Andrew Foy, co-author of a new study and an associate professor of medicine at Penn State. By Ed Silverman Adobe Ozempic-like drugs linked to low, but increased risk of post-endoscopy pneumonia, study finds Drugs like Ozempic were linked to a low, but greater risk of aspiration pneumonia following endoscopies, a new study found. By Elaine Chen

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser